The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1404
Healthcare Clients
4626
Total Healthcare Names
16
Obesity Names
Animal Health - 27
Antibiotic - 114
Antifungal - 29
Antiviral - 134
Antiviral/HIV - 52
Biologic Suffix - 62
Biosimilar Name - 29
Cardiovascular - 212
Class Name - 9
Clinical Trial Name - 124
Corporate Identity - 134
COVID-19 - 31
Covid-19 - 32
Dermatology - 157
Division Identity - 15
Endocrinology - 195
Gastrointestinal - 125
Hematology - 166
Identity Research - 15
Immunology - 273
Line Extension - 1
Medical Device - 268
Men's Health - 11
Metabolic Disorders - 89
Musculoskeletal - 42
Nephrology - 36
Neurology - 405
Nutritional Agent - 52
Obesity - 16
Oncology - 864
Ophthalmology - 160
Oral Care - 8
OTC - 172
Pain & Inflammation - 172
Product Identity - 7
Program Name - 22
Respiratory - 231
Service Name - 17
Tagline - 12
Technology Name - 36
Urology - 27
USAN/INN - 1613
Vaccine - 113
Website - 24
Women's Health - 147
* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ALIZYMECETILISTAT Obesity
CITIUS PHARMASUPRENZA Obesity
EISAIBELVIQ *Obesity
HALEONALLI Obesity
J&J INNOVATIVE MEDICINEefinopegdutide Obesity
NOVO NORDISKSAXENDA *Obesity
OREXIGEN THERAPEUTICSCONTRAVE *Obesity
PFIZERREDUX Obesity
RHYTHM PHARMACEUTICALSIMCIVREE *Obesity
RIEMSERALVALIN Obesity
ROCHEXENICAL Obesity
SANOFIACOMPLIA *Obesity
SHIONOGI PHARMAvelneperit Obesity
TAKEDAOBLEAN (オブリーン) Obesity
VIVUSQSYMIA *Obesity
ZAFGENaclimostat Obesity